Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

VIMRxyn enters phase II for treatment of skin diseases

Oct. 27, 1997

Topical antiinflammatory activity of COX-2 inhibitors assessed

Oct. 27, 1997

ARS discloses new 5alpha-reductase inhibitors

Oct. 27, 1997

ADCON-L up for advisory committee review

Oct. 24, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

Zorac introduced in U.K. for psoriasis

Oct. 22, 1997

Peptech and Allergan terminate collaboration on GMDP

Oct. 20, 1997

Integra Artificial Skin receives approval in Taiwan

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...